BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)

OBJECTIVE: To evaluate the prognostic significance of detectable circulating cell-free DNA (cfDNA) BRAF V600E/K mutations in patients with advanced melanoma enrolled in a clinical trial without BRAF-targeted therapy. PATIENTS AND METHODS: BRAF V600E/K mutation status was determined on archived tissu...

Descripción completa

Detalles Bibliográficos
Autores principales: Slostad, Jessica A., Liu, Minetta C., Allred, Jacob B., Erickson, Lori A., Rumilla, Kandelaria M., Block, Matthew S., Keppen, Michael, King, David, Markovic, Svetomir N., McWilliams, Robert R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526905/
https://www.ncbi.nlm.nih.gov/pubmed/34703985
http://dx.doi.org/10.1016/j.mayocpiqo.2021.05.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526905/
https://www.ncbi.nlm.nih.gov/pubmed/34703985
http://dx.doi.org/10.1016/j.mayocpiqo.2021.05.003

Ejemplares similares